These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 24522333

  • 1. Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
    Alburges ME, Hoonakker AJ, Cordova NM, Robson CM, McFadden LM, Martin AL, Hanson GR.
    Psychopharmacology (Berl); 2014 Aug; 231(15):2933-40. PubMed ID: 24522333
    [Abstract] [Full Text] [Related]

  • 2. Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.
    Alburges ME, Hoonakker AJ, Cordova NM, Robson CM, McFadden LM, Martin AL, Hanson GR.
    Synapse; 2015 Aug; 69(8):396-404. PubMed ID: 25963809
    [Abstract] [Full Text] [Related]

  • 3. Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia.
    Frankel PS, Hoonakker AJ, Alburges ME, McDougall JW, McFadden LM, Fleckenstein AE, Hanson GR.
    J Pharmacol Exp Ther; 2011 Mar; 336(3):809-15. PubMed ID: 21131268
    [Abstract] [Full Text] [Related]

  • 4. Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.
    Hanson GR, Hoonakker AJ, Robson CM, McFadden LM, Frankel PS, Alburges ME.
    J Pharmacol Exp Ther; 2013 Aug; 346(2):173-81. PubMed ID: 23685547
    [Abstract] [Full Text] [Related]

  • 5. Differential response of neurotensin to methamphetamine self-administration.
    Frankel PS, Hoonakker AJ, Hanson GR.
    Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
    [Abstract] [Full Text] [Related]

  • 6. Mephedrone alters basal ganglia and limbic neurotensin systems.
    German CL, Hoonakker AH, Fleckenstein AE, Hanson GR.
    J Neurochem; 2014 Aug; 130(3):402-7. PubMed ID: 24678634
    [Abstract] [Full Text] [Related]

  • 7. Nicotinic and dopamine D2 receptors mediate nicotine-induced changes in ventral tegmental area neurotensin system.
    Alburges ME, Hoonakker AJ, Hanson GR.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):124-32. PubMed ID: 17689525
    [Abstract] [Full Text] [Related]

  • 8. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
    Alburges ME, Hoonakker AJ, Horner KA, Fleckenstein AE, Hanson GR.
    J Neurochem; 2011 May 14; 117(3):470-8. PubMed ID: 21323925
    [Abstract] [Full Text] [Related]

  • 9. Distinct responses of basal ganglia substance P systems to low and high doses of methamphetamine.
    Hanson GR, Bush L, Keefe KA, Alburges ME.
    J Neurochem; 2002 Sep 14; 82(5):1171-8. PubMed ID: 12358764
    [Abstract] [Full Text] [Related]

  • 10. Response of limbic neurotensin systems to methamphetamine self-administration.
    Hanson GR, Hoonakker AJ, Alburges ME, McFadden LM, Robson CM, Frankel PS.
    Neuroscience; 2012 Feb 17; 203():99-107. PubMed ID: 22245499
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
    Hadlock GC, Baucum AJ, King JL, Horner KA, Cook GA, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2009 Apr 17; 329(1):169-74. PubMed ID: 19141713
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum.
    Beauvais G, Jayanthi S, McCoy MT, Ladenheim B, Cadet JL.
    Brain Res; 2010 Mar 08; 1318():1-10. PubMed ID: 20059987
    [Abstract] [Full Text] [Related]

  • 13. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW, Morford LL, Vorhees CV.
    Synapse; 2005 May 08; 56(2):84-93. PubMed ID: 15714503
    [Abstract] [Full Text] [Related]

  • 14. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
    Mohd-Yusof A, Veliz A, Rudberg KN, Stone MJ, Gonzalez AE, McDougall SA.
    Psychopharmacology (Berl); 2016 Mar 08; 233(5):893-903. PubMed ID: 26650612
    [Abstract] [Full Text] [Related]

  • 15. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM, Bush LG, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1990 Nov 08; 255(2):775-80. PubMed ID: 2147039
    [Abstract] [Full Text] [Related]

  • 16. Contrasting responses by basal ganglia met-enkephalin systems to low and high doses of methamphetamine in a rat model.
    Alburges ME, Keefe KA, Hanson GR.
    J Neurochem; 2001 Feb 08; 76(3):721-9. PubMed ID: 11158242
    [Abstract] [Full Text] [Related]

  • 17. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC, Miller JR, Dohrmann JM, Caine SB.
    Neuropharmacology; 2004 Feb 08; 47 Suppl 1():256-73. PubMed ID: 15464142
    [Abstract] [Full Text] [Related]

  • 18. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    Wagstaff JD, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1996 Aug 08; 278(2):547-54. PubMed ID: 8768703
    [Abstract] [Full Text] [Related]

  • 19. Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats.
    Brennan KA, Carati C, Lea RA, Fitzmaurice PS, Schenk S.
    Behav Pharmacol; 2009 Dec 08; 20(8):688-94. PubMed ID: 19881334
    [Abstract] [Full Text] [Related]

  • 20. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
    Lindgren HS, Ohlin KE, Cenci MA.
    Neuropsychopharmacology; 2009 Nov 08; 34(12):2477-88. PubMed ID: 19606087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.